| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 190 | 2024 | 2905 | 9.980 |
Why?
|
| Particulate Matter | 187 | 2024 | 2607 | 8.920 |
Why?
|
| Air Pollution | 131 | 2024 | 2367 | 8.270 |
Why?
|
| Environmental Exposure | 145 | 2024 | 4538 | 6.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 60 | 2024 | 2541 | 3.960 |
Why?
|
| Maternal Exposure | 49 | 2024 | 1083 | 3.940 |
Why?
|
| Environmental Monitoring | 70 | 2021 | 1466 | 3.780 |
Why?
|
| Environmental Pollutants | 24 | 2024 | 1290 | 3.200 |
Why?
|
| Soot | 30 | 2024 | 219 | 2.960 |
Why?
|
| Vehicle Emissions | 39 | 2019 | 651 | 2.930 |
Why?
|
| Air Pollution, Indoor | 32 | 2025 | 918 | 2.640 |
Why?
|
| Bayes Theorem | 45 | 2024 | 2357 | 2.490 |
Why?
|
| Inhalation Exposure | 24 | 2020 | 431 | 2.170 |
Why?
|
| Models, Statistical | 38 | 2023 | 5107 | 2.080 |
Why?
|
| Respiratory Tract Diseases | 9 | 2019 | 744 | 1.570 |
Why?
|
| Asthma | 35 | 2024 | 6293 | 1.560 |
Why?
|
| Radon | 8 | 2025 | 90 | 1.490 |
Why?
|
| Birth Weight | 24 | 2023 | 2108 | 1.410 |
Why?
|
| Biostatistics | 4 | 2020 | 165 | 1.340 |
Why?
|
| Biometry | 12 | 2016 | 570 | 1.300 |
Why?
|
| Pregnancy | 123 | 2024 | 30175 | 1.290 |
Why?
|
| DNA Methylation | 28 | 2023 | 4432 | 1.290 |
Why?
|
| Aircraft | 3 | 2019 | 135 | 1.280 |
Why?
|
| Particle Size | 51 | 2023 | 1652 | 1.280 |
Why?
|
| Temperature | 18 | 2024 | 2235 | 1.220 |
Why?
|
| Censuses | 7 | 2023 | 198 | 1.210 |
Why?
|
| Linear Models | 41 | 2021 | 5890 | 1.190 |
Why?
|
| Respiratory Sounds | 10 | 2022 | 702 | 1.180 |
Why?
|
| Metals | 10 | 2023 | 713 | 1.170 |
Why?
|
| Manganese | 12 | 2023 | 394 | 1.150 |
Why?
|
| Air Pollutants, Radioactive | 7 | 2025 | 56 | 1.110 |
Why?
|
| Radioactivity | 6 | 2023 | 59 | 1.110 |
Why?
|
| Occupational Diseases | 5 | 2018 | 1458 | 1.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 18 | 2024 | 3253 | 1.060 |
Why?
|
| Boston | 68 | 2024 | 9375 | 1.050 |
Why?
|
| Carbon | 17 | 2016 | 672 | 1.040 |
Why?
|
| Fluorocarbons | 9 | 2023 | 506 | 0.980 |
Why?
|
| Nitrogen Dioxide | 19 | 2024 | 533 | 0.940 |
Why?
|
| Residence Characteristics | 20 | 2024 | 2122 | 0.910 |
Why?
|
| Seasons | 31 | 2024 | 1523 | 0.910 |
Why?
|
| Data Interpretation, Statistical | 16 | 2017 | 2714 | 0.910 |
Why?
|
| Regression Analysis | 17 | 2018 | 6346 | 0.900 |
Why?
|
| Arsenic | 8 | 2022 | 358 | 0.870 |
Why?
|
| Humans | 449 | 2025 | 768887 | 0.870 |
Why?
|
| Mortality | 19 | 2022 | 2915 | 0.810 |
Why?
|
| Aerospace Medicine | 3 | 2018 | 95 | 0.810 |
Why?
|
| Power Plants | 6 | 2011 | 125 | 0.790 |
Why?
|
| Female | 284 | 2024 | 397464 | 0.780 |
Why?
|
| Urban Population | 21 | 2023 | 2045 | 0.780 |
Why?
|
| Massachusetts | 44 | 2024 | 8888 | 0.720 |
Why?
|
| Male | 276 | 2024 | 365249 | 0.720 |
Why?
|
| Housing | 14 | 2025 | 680 | 0.720 |
Why?
|
| Hydrocortisone | 8 | 2022 | 1842 | 0.700 |
Why?
|
| Aging | 32 | 2024 | 8765 | 0.700 |
Why?
|
| Aerosols | 13 | 2018 | 636 | 0.690 |
Why?
|
| Oxidative Stress | 20 | 2023 | 3138 | 0.690 |
Why?
|
| Child Development | 10 | 2020 | 2337 | 0.670 |
Why?
|
| Humidity | 5 | 2024 | 207 | 0.670 |
Why?
|
| Lead | 10 | 2021 | 880 | 0.670 |
Why?
|
| Population Groups | 1 | 2020 | 208 | 0.670 |
Why?
|
| Socioeconomic Factors | 19 | 2024 | 7860 | 0.660 |
Why?
|
| Environmental Health | 4 | 2018 | 297 | 0.630 |
Why?
|
| Computer Simulation | 22 | 2023 | 6289 | 0.630 |
Why?
|
| Homicide | 4 | 2017 | 294 | 0.620 |
Why?
|
| Heart Rate | 19 | 2024 | 4217 | 0.610 |
Why?
|
| Mexico | 16 | 2024 | 769 | 0.610 |
Why?
|
| Aviation | 1 | 2018 | 49 | 0.600 |
Why?
|
| Ozone | 14 | 2024 | 496 | 0.600 |
Why?
|
| Schools | 8 | 2021 | 1498 | 0.590 |
Why?
|
| Hydrocarbons, Chlorinated | 4 | 2023 | 120 | 0.590 |
Why?
|
| Alkanesulfonic Acids | 6 | 2023 | 203 | 0.590 |
Why?
|
| Health Surveys | 9 | 2019 | 4055 | 0.580 |
Why?
|
| Blood Pressure | 17 | 2020 | 8541 | 0.580 |
Why?
|
| DNA, Mitochondrial | 7 | 2021 | 871 | 0.570 |
Why?
|
| Clothing | 1 | 2018 | 96 | 0.570 |
Why?
|
| Health Status Disparities | 7 | 2020 | 1886 | 0.560 |
Why?
|
| Pregnancy Outcome | 6 | 2024 | 2957 | 0.560 |
Why?
|
| Cohort Studies | 69 | 2024 | 41800 | 0.550 |
Why?
|
| Longitudinal Studies | 33 | 2021 | 14795 | 0.540 |
Why?
|
| United States | 84 | 2025 | 73180 | 0.540 |
Why?
|
| Infant, Newborn | 50 | 2024 | 26394 | 0.530 |
Why?
|
| Aged | 139 | 2024 | 171790 | 0.530 |
Why?
|
| Epigenesis, Genetic | 12 | 2024 | 3836 | 0.530 |
Why?
|
| Poverty | 7 | 2024 | 2720 | 0.520 |
Why?
|
| Polychlorinated Biphenyls | 3 | 2023 | 235 | 0.520 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2019 | 828 | 0.520 |
Why?
|
| Flame Retardants | 3 | 2021 | 97 | 0.510 |
Why?
|
| Cardiovascular Diseases | 20 | 2024 | 15662 | 0.510 |
Why?
|
| Stress, Psychological | 13 | 2024 | 4542 | 0.510 |
Why?
|
| Hypersensitivity | 5 | 2019 | 1173 | 0.510 |
Why?
|
| Infant Mortality | 3 | 2015 | 751 | 0.500 |
Why?
|
| Phthalic Acids | 5 | 2024 | 484 | 0.500 |
Why?
|
| Vital Capacity | 8 | 2020 | 997 | 0.500 |
Why?
|
| Occupational Exposure | 5 | 2019 | 1807 | 0.500 |
Why?
|
| Arrhythmias, Cardiac | 10 | 2024 | 2258 | 0.490 |
Why?
|
| Child | 80 | 2024 | 80969 | 0.490 |
Why?
|
| Solar Activity | 4 | 2024 | 44 | 0.480 |
Why?
|
| Airway Obstruction | 1 | 2020 | 672 | 0.480 |
Why?
|
| Fetal Development | 7 | 2023 | 771 | 0.470 |
Why?
|
| Selection Bias | 1 | 2016 | 360 | 0.470 |
Why?
|
| Prospective Studies | 61 | 2024 | 54950 | 0.460 |
Why?
|
| Endocrine Disruptors | 3 | 2024 | 264 | 0.460 |
Why?
|
| Inflammation | 20 | 2024 | 10869 | 0.460 |
Why?
|
| Models, Theoretical | 18 | 2019 | 3580 | 0.460 |
Why?
|
| Epidemiology | 2 | 2018 | 278 | 0.450 |
Why?
|
| Forced Expiratory Volume | 9 | 2020 | 1832 | 0.450 |
Why?
|
| Cognition | 15 | 2024 | 7080 | 0.450 |
Why?
|
| Violence | 3 | 2017 | 936 | 0.440 |
Why?
|
| Human Rights Abuses | 1 | 2013 | 34 | 0.440 |
Why?
|
| Dibutyl Phthalate | 3 | 2018 | 29 | 0.440 |
Why?
|
| Abortion, Legal | 1 | 2015 | 121 | 0.430 |
Why?
|
| Adult | 125 | 2024 | 223818 | 0.430 |
Why?
|
| Lung | 17 | 2022 | 10097 | 0.430 |
Why?
|
| Causality | 3 | 2021 | 1255 | 0.420 |
Why?
|
| Young Adult | 64 | 2024 | 60110 | 0.420 |
Why?
|
| Infant | 41 | 2024 | 36541 | 0.410 |
Why?
|
| Urban Health | 8 | 2020 | 535 | 0.410 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 3421 | 0.410 |
Why?
|
| Veterans | 8 | 2022 | 2672 | 0.400 |
Why?
|
| Sulfates | 9 | 2017 | 379 | 0.400 |
Why?
|
| Middle Aged | 113 | 2024 | 223740 | 0.390 |
Why?
|
| Environment | 4 | 2019 | 1125 | 0.390 |
Why?
|
| Cities | 11 | 2020 | 543 | 0.390 |
Why?
|
| Social Justice | 2 | 2024 | 486 | 0.390 |
Why?
|
| Adolescent | 68 | 2024 | 89247 | 0.390 |
Why?
|
| Population Dynamics | 1 | 2013 | 314 | 0.380 |
Why?
|
| Autonomic Nervous System | 4 | 2019 | 709 | 0.380 |
Why?
|
| Menarche | 2 | 2024 | 538 | 0.380 |
Why?
|
| Hazardous Substances | 3 | 2017 | 153 | 0.370 |
Why?
|
| Body Mass Index | 11 | 2024 | 13054 | 0.370 |
Why?
|
| Epigenomics | 4 | 2024 | 961 | 0.360 |
Why?
|
| Remote Sensing Technology | 4 | 2017 | 92 | 0.350 |
Why?
|
| Aged, 80 and over | 67 | 2024 | 59738 | 0.350 |
Why?
|
| Premature Birth | 6 | 2024 | 1814 | 0.350 |
Why?
|
| Hot Temperature | 5 | 2023 | 1440 | 0.340 |
Why?
|
| Child, Preschool | 43 | 2024 | 42684 | 0.340 |
Why?
|
| Privacy | 2 | 2023 | 233 | 0.340 |
Why?
|
| Temperament | 3 | 2024 | 301 | 0.340 |
Why?
|
| Gamma Rays | 3 | 2020 | 319 | 0.340 |
Why?
|
| Radiation Monitoring | 4 | 2025 | 106 | 0.340 |
Why?
|
| Toxicity Tests | 6 | 2011 | 114 | 0.340 |
Why?
|
| Phenytoin | 6 | 2005 | 189 | 0.340 |
Why?
|
| Depression | 13 | 2023 | 8240 | 0.330 |
Why?
|
| Dust | 9 | 2024 | 488 | 0.330 |
Why?
|
| Infant, Low Birth Weight | 4 | 2019 | 868 | 0.330 |
Why?
|
| Coal | 7 | 2023 | 122 | 0.330 |
Why?
|
| Carbon Monoxide | 8 | 2019 | 552 | 0.330 |
Why?
|
| Hair | 5 | 2020 | 509 | 0.320 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6982 | 0.320 |
Why?
|
| Skin Diseases | 1 | 2018 | 1085 | 0.320 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2021 | 456 | 0.320 |
Why?
|
| Oxidants, Photochemical | 3 | 2017 | 77 | 0.320 |
Why?
|
| Spacecraft | 4 | 2017 | 28 | 0.320 |
Why?
|
| United States Environmental Protection Agency | 8 | 2020 | 139 | 0.310 |
Why?
|
| Metals, Heavy | 2 | 2016 | 149 | 0.310 |
Why?
|
| Endothelium | 3 | 2020 | 768 | 0.310 |
Why?
|
| Hypertension | 10 | 2020 | 8615 | 0.310 |
Why?
|
| Cross-Over Studies | 12 | 2019 | 2108 | 0.310 |
Why?
|
| New England | 8 | 2023 | 1058 | 0.310 |
Why?
|
| Nutrition Surveys | 6 | 2023 | 1738 | 0.310 |
Why?
|
| Nails | 6 | 2022 | 298 | 0.310 |
Why?
|
| Food Supply | 2 | 2024 | 544 | 0.310 |
Why?
|
| Family Characteristics | 5 | 2023 | 1002 | 0.300 |
Why?
|
| Endotoxins | 3 | 2015 | 520 | 0.300 |
Why?
|
| Menstrual Cycle | 4 | 2024 | 546 | 0.300 |
Why?
|
| Mercury | 3 | 2022 | 289 | 0.300 |
Why?
|
| Live Birth | 2 | 2023 | 516 | 0.300 |
Why?
|
| Epidemiologic Studies | 4 | 2023 | 677 | 0.300 |
Why?
|
| Gestational Age | 12 | 2023 | 3610 | 0.300 |
Why?
|
| Hospitalization | 8 | 2024 | 10845 | 0.290 |
Why?
|
| Abnormalities, Drug-Induced | 7 | 2005 | 337 | 0.290 |
Why?
|
| Phenols | 2 | 2024 | 523 | 0.290 |
Why?
|
| Sex Factors | 20 | 2021 | 10641 | 0.280 |
Why?
|
| Income | 5 | 2015 | 1878 | 0.280 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2359 | 0.270 |
Why?
|
| Dogs | 10 | 2017 | 3845 | 0.270 |
Why?
|
| Automobiles | 2 | 2018 | 103 | 0.270 |
Why?
|
| Geologic Sediments | 2 | 2004 | 81 | 0.270 |
Why?
|
| Cause of Death | 5 | 2020 | 3721 | 0.270 |
Why?
|
| Fetal Blood | 7 | 2019 | 1360 | 0.260 |
Why?
|
| Noise, Transportation | 2 | 2018 | 60 | 0.260 |
Why?
|
| Bone Density | 4 | 2020 | 3573 | 0.260 |
Why?
|
| Police | 2 | 2019 | 158 | 0.260 |
Why?
|
| Vitamin B Complex | 2 | 2019 | 299 | 0.260 |
Why?
|
| Cough | 2 | 2024 | 598 | 0.260 |
Why?
|
| Cross-Sectional Studies | 24 | 2024 | 26384 | 0.260 |
Why?
|
| Infertility, Female | 2 | 2024 | 764 | 0.260 |
Why?
|
| Epidemiologic Methods | 3 | 2008 | 1328 | 0.250 |
Why?
|
| Decanoic Acids | 3 | 2021 | 69 | 0.250 |
Why?
|
| Prenatal Care | 1 | 2013 | 1159 | 0.250 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 2016 | 1133 | 0.240 |
Why?
|
| Respiratory Function Tests | 11 | 2020 | 1695 | 0.240 |
Why?
|
| Cluster Analysis | 7 | 2020 | 2730 | 0.240 |
Why?
|
| Obesity | 9 | 2024 | 13087 | 0.240 |
Why?
|
| Fertilization in Vitro | 3 | 2019 | 1302 | 0.240 |
Why?
|
| Folic Acid | 4 | 2023 | 1336 | 0.240 |
Why?
|
| Prevalence | 10 | 2019 | 15875 | 0.240 |
Why?
|
| Fibrinogen | 5 | 2017 | 892 | 0.240 |
Why?
|
| Smoke | 3 | 2016 | 236 | 0.240 |
Why?
|
| Mass Media | 2 | 2017 | 303 | 0.230 |
Why?
|
| Disease Susceptibility | 3 | 2010 | 1794 | 0.230 |
Why?
|
| Population Surveillance | 3 | 2014 | 2597 | 0.230 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2019 | 301 | 0.230 |
Why?
|
| Risk Factors | 41 | 2024 | 74971 | 0.230 |
Why?
|
| Bangladesh | 5 | 2019 | 741 | 0.230 |
Why?
|
| Incidence | 14 | 2024 | 21545 | 0.230 |
Why?
|
| Benzophenones | 1 | 2024 | 57 | 0.230 |
Why?
|
| Ventricular Premature Complexes | 3 | 2023 | 112 | 0.230 |
Why?
|
| Cooking | 6 | 2016 | 314 | 0.230 |
Why?
|
| Myocardial Ischemia | 6 | 2024 | 2139 | 0.220 |
Why?
|
| Telomere | 4 | 2023 | 943 | 0.220 |
Why?
|
| Saliva | 4 | 2019 | 855 | 0.220 |
Why?
|
| Time Factors | 28 | 2024 | 40266 | 0.210 |
Why?
|
| Logistic Models | 13 | 2021 | 13317 | 0.210 |
Why?
|
| Heart | 6 | 2019 | 4448 | 0.210 |
Why?
|
| Copper | 2 | 2023 | 369 | 0.210 |
Why?
|
| Adipokines | 2 | 2017 | 309 | 0.210 |
Why?
|
| Water Pollutants, Chemical | 4 | 2017 | 359 | 0.210 |
Why?
|
| Weather | 5 | 2019 | 234 | 0.210 |
Why?
|
| Anticonvulsants | 5 | 2005 | 1924 | 0.210 |
Why?
|
| Myocardial Infarction | 14 | 2022 | 11521 | 0.210 |
Why?
|
| Leukocytes | 4 | 2022 | 2034 | 0.210 |
Why?
|
| Stroke | 11 | 2023 | 9756 | 0.210 |
Why?
|
| Executive Function | 3 | 2022 | 1405 | 0.210 |
Why?
|
| Caprylates | 2 | 2021 | 115 | 0.200 |
Why?
|
| Nickel | 2 | 2020 | 126 | 0.200 |
Why?
|
| Tooth | 2 | 2021 | 210 | 0.200 |
Why?
|
| Arsenicals | 2 | 2019 | 117 | 0.200 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 590 | 0.200 |
Why?
|
| Pregnancy Complications | 5 | 2020 | 2965 | 0.200 |
Why?
|
| Mesalamine | 3 | 2018 | 134 | 0.200 |
Why?
|
| Mumps | 1 | 2023 | 71 | 0.200 |
Why?
|
| Radiation Injuries | 2 | 2020 | 1203 | 0.200 |
Why?
|
| Leukocyte Count | 2 | 2020 | 1609 | 0.200 |
Why?
|
| Social Class | 6 | 2016 | 2009 | 0.200 |
Why?
|
| Malus | 1 | 2022 | 51 | 0.190 |
Why?
|
| Rodent Control | 1 | 2021 | 15 | 0.190 |
Why?
|
| Beta Particles | 2 | 2020 | 51 | 0.190 |
Why?
|
| Facial Bones | 1 | 2003 | 209 | 0.190 |
Why?
|
| Women's Health | 6 | 2023 | 2081 | 0.190 |
Why?
|
| Seawater | 3 | 2016 | 126 | 0.190 |
Why?
|
| Nitrates | 2 | 2017 | 260 | 0.190 |
Why?
|
| Sulfur | 2 | 2017 | 158 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 5 | 2024 | 1486 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2020 | 2277 | 0.190 |
Why?
|
| Parabens | 2 | 2024 | 117 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 10397 | 0.190 |
Why?
|
| Italy | 5 | 2023 | 855 | 0.190 |
Why?
|
| Satellite Communications | 3 | 2015 | 13 | 0.190 |
Why?
|
| Nurses | 2 | 2023 | 2501 | 0.190 |
Why?
|
| Pollen | 1 | 2001 | 80 | 0.180 |
Why?
|
| Aging, Premature | 1 | 2021 | 44 | 0.180 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2022 | 705 | 0.180 |
Why?
|
| Pregnancy Trimesters | 2 | 2023 | 197 | 0.180 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 692 | 0.180 |
Why?
|
| Lymphocyte Count | 2 | 2020 | 793 | 0.180 |
Why?
|
| Tooth, Deciduous | 2 | 2018 | 76 | 0.180 |
Why?
|
| Allergens | 4 | 2021 | 1444 | 0.180 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2018 | 99 | 0.180 |
Why?
|
| Interleukin-6 | 7 | 2024 | 3233 | 0.180 |
Why?
|
| Electrocardiography, Ambulatory | 6 | 2009 | 582 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2665 | 0.180 |
Why?
|
| Glutathione Transferase | 4 | 2019 | 564 | 0.170 |
Why?
|
| Intelligence | 3 | 2020 | 927 | 0.170 |
Why?
|
| Likelihood Functions | 5 | 2011 | 993 | 0.170 |
Why?
|
| Paternal Exposure | 1 | 2020 | 99 | 0.170 |
Why?
|
| United States Department of Veterans Affairs | 6 | 2017 | 941 | 0.170 |
Why?
|
| Pesticides | 1 | 2022 | 298 | 0.170 |
Why?
|
| Sample Size | 3 | 2023 | 848 | 0.170 |
Why?
|
| Mining | 2 | 2017 | 93 | 0.170 |
Why?
|
| Selenium | 1 | 2022 | 418 | 0.170 |
Why?
|
| Hemodynamics | 3 | 2015 | 4199 | 0.170 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2024 | 383 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2021 | 6434 | 0.160 |
Why?
|
| ROC Curve | 3 | 2003 | 3629 | 0.160 |
Why?
|
| Quinolinic Acid | 1 | 2019 | 67 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 585 | 0.160 |
Why?
|
| Odds Ratio | 12 | 2021 | 9682 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2024 | 644 | 0.160 |
Why?
|
| Vitamin B 6 | 2 | 2017 | 237 | 0.160 |
Why?
|
| Meconium | 1 | 2019 | 47 | 0.160 |
Why?
|
| Plant Proteins | 1 | 2001 | 376 | 0.160 |
Why?
|
| Rats | 18 | 2019 | 23847 | 0.160 |
Why?
|
| Models, Biological | 6 | 2012 | 9499 | 0.150 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 534 | 0.150 |
Why?
|
| Age Factors | 17 | 2024 | 18454 | 0.150 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 259 | 0.150 |
Why?
|
| Postmenopause | 2 | 2019 | 2519 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2017 | 8200 | 0.150 |
Why?
|
| Climate | 1 | 2019 | 146 | 0.150 |
Why?
|
| Parturition | 2 | 2023 | 453 | 0.150 |
Why?
|
| Risk | 11 | 2019 | 9621 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2018 | 467 | 0.150 |
Why?
|
| Alloys | 1 | 2018 | 111 | 0.150 |
Why?
|
| Skull | 1 | 2003 | 830 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 12252 | 0.150 |
Why?
|
| Diabetes, Gestational | 3 | 2024 | 1260 | 0.150 |
Why?
|
| Geography | 3 | 2015 | 654 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2023 | 3982 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2023 | 1767 | 0.150 |
Why?
|
| Alaska | 1 | 2018 | 68 | 0.150 |
Why?
|
| Dentin | 1 | 2018 | 75 | 0.150 |
Why?
|
| Calibration | 6 | 2022 | 823 | 0.150 |
Why?
|
| Body Composition | 2 | 2018 | 2461 | 0.150 |
Why?
|
| Wood | 2 | 2015 | 92 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 355 | 0.150 |
Why?
|
| Baroreflex | 2 | 2017 | 154 | 0.150 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 30 | 0.150 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2017 | 70 | 0.150 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2019 | 503 | 0.150 |
Why?
|
| Confidence Intervals | 4 | 2019 | 2931 | 0.150 |
Why?
|
| Plasticizers | 1 | 2017 | 52 | 0.140 |
Why?
|
| Neutrophils | 5 | 2020 | 3785 | 0.140 |
Why?
|
| Pest Control | 1 | 2017 | 29 | 0.140 |
Why?
|
| Endocrine Glands | 1 | 2017 | 101 | 0.140 |
Why?
|
| Hypospadias | 1 | 2018 | 98 | 0.140 |
Why?
|
| Ecosystem | 1 | 2021 | 494 | 0.140 |
Why?
|
| Cryptorchidism | 1 | 2018 | 153 | 0.140 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 528 | 0.140 |
Why?
|
| Child Behavior | 2 | 2020 | 865 | 0.140 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 68 | 0.140 |
Why?
|
| Iron | 2 | 2023 | 1813 | 0.140 |
Why?
|
| Patient Admission | 2 | 2015 | 1369 | 0.140 |
Why?
|
| Fungi | 2 | 2022 | 345 | 0.140 |
Why?
|
| Binomial Distribution | 1 | 1996 | 23 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 2018 | 163 | 0.140 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 983 | 0.140 |
Why?
|
| Pre-Eclampsia | 2 | 2024 | 1251 | 0.140 |
Why?
|
| Halogenated Diphenyl Ethers | 3 | 2021 | 83 | 0.140 |
Why?
|
| Death Certificates | 1 | 2017 | 172 | 0.130 |
Why?
|
| C-Reactive Protein | 9 | 2024 | 3858 | 0.130 |
Why?
|
| Phenobarbital | 5 | 2005 | 192 | 0.130 |
Why?
|
| Guideline Adherence | 2 | 2005 | 2240 | 0.130 |
Why?
|
| Herbicides | 1 | 2017 | 103 | 0.130 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 117 | 0.130 |
Why?
|
| Environment Design | 1 | 2018 | 174 | 0.130 |
Why?
|
| Cosmetics | 1 | 2017 | 102 | 0.130 |
Why?
|
| Law Enforcement | 1 | 2017 | 112 | 0.130 |
Why?
|
| Animals | 39 | 2022 | 169408 | 0.130 |
Why?
|
| Dinoprost | 1 | 2016 | 139 | 0.130 |
Why?
|
| Los Angeles | 3 | 2011 | 245 | 0.130 |
Why?
|
| Nitrogen Oxides | 4 | 2017 | 128 | 0.130 |
Why?
|
| Cold Temperature | 2 | 2017 | 791 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 407 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 371 | 0.120 |
Why?
|
| Smoking | 5 | 2019 | 9094 | 0.120 |
Why?
|
| Rural Health | 1 | 2017 | 300 | 0.120 |
Why?
|
| Developing Countries | 2 | 2018 | 2906 | 0.120 |
Why?
|
| Language Development | 1 | 2016 | 184 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 812 | 0.120 |
Why?
|
| Insecticides | 1 | 2017 | 199 | 0.120 |
Why?
|
| Postpartum Period | 2 | 2022 | 1198 | 0.120 |
Why?
|
| Meningomyelocele | 1 | 2017 | 182 | 0.120 |
Why?
|
| Sperm Motility | 1 | 2016 | 266 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 551 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2020 | 668 | 0.120 |
Why?
|
| Georgia | 2 | 2013 | 186 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2024 | 523 | 0.120 |
Why?
|
| Polychaeta | 2 | 2004 | 5 | 0.120 |
Why?
|
| Nasal Mucosa | 1 | 2018 | 416 | 0.120 |
Why?
|
| Fingers | 5 | 2005 | 512 | 0.120 |
Why?
|
| Optical Phenomena | 1 | 2015 | 105 | 0.120 |
Why?
|
| Brugada Syndrome | 1 | 2016 | 98 | 0.120 |
Why?
|
| Acetaminophen | 1 | 2019 | 556 | 0.120 |
Why?
|
| Minority Health | 1 | 2015 | 79 | 0.120 |
Why?
|
| Pregnant Women | 2 | 2018 | 571 | 0.120 |
Why?
|
| Diet, Reducing | 1 | 2018 | 487 | 0.120 |
Why?
|
| Respiration | 2 | 2011 | 1668 | 0.120 |
Why?
|
| beta-Glucans | 1 | 2015 | 129 | 0.120 |
Why?
|
| Immunoglobulin E | 4 | 2018 | 1506 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 272 | 0.110 |
Why?
|
| Nervous System | 1 | 2017 | 547 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 2736 | 0.110 |
Why?
|
| Proportional Hazards Models | 10 | 2020 | 12563 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2024 | 1252 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 39394 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 899 | 0.110 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 579 | 0.110 |
Why?
|
| Psychotic Disorders | 2 | 2022 | 3279 | 0.110 |
Why?
|
| Semen | 1 | 2016 | 349 | 0.110 |
Why?
|
| Radon Daughters | 2 | 2023 | 11 | 0.110 |
Why?
|
| School Health Services | 1 | 2017 | 388 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2022 | 3811 | 0.110 |
Why?
|
| Coronary Artery Disease | 5 | 2016 | 6569 | 0.110 |
Why?
|
| Erectile Dysfunction | 1 | 2017 | 445 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2020 | 3446 | 0.110 |
Why?
|
| Educational Status | 3 | 2018 | 2515 | 0.110 |
Why?
|
| Coronary Circulation | 2 | 2010 | 1617 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 403 | 0.110 |
Why?
|
| Neoplasms | 3 | 2020 | 22390 | 0.110 |
Why?
|
| Firearms | 2 | 2017 | 632 | 0.100 |
Why?
|
| Life Change Events | 2 | 2015 | 962 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 2013 | 144 | 0.100 |
Why?
|
| Cockroaches | 2 | 2017 | 92 | 0.100 |
Why?
|
| Peroxidase | 1 | 2016 | 610 | 0.100 |
Why?
|
| Colombia | 1 | 2013 | 287 | 0.100 |
Why?
|
| Stress, Physiological | 2 | 2017 | 1410 | 0.100 |
Why?
|
| Data Collection | 3 | 2021 | 3322 | 0.100 |
Why?
|
| Climate Change | 1 | 2019 | 509 | 0.100 |
Why?
|
| Toes | 2 | 2005 | 209 | 0.100 |
Why?
|
| Rural Population | 4 | 2021 | 2322 | 0.100 |
Why?
|
| Civil Rights | 1 | 2013 | 131 | 0.100 |
Why?
|
| Sex Characteristics | 3 | 2018 | 2660 | 0.100 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1890 | 0.100 |
Why?
|
| SEER Program | 2 | 2015 | 1473 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2014 | 373 | 0.100 |
Why?
|
| Placenta | 2 | 2023 | 1721 | 0.100 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 761 | 0.100 |
Why?
|
| Longevity | 1 | 2019 | 1077 | 0.100 |
Why?
|
| Retroelements | 1 | 2013 | 163 | 0.100 |
Why?
|
| Transition Elements | 1 | 2011 | 15 | 0.100 |
Why?
|
| Self Report | 3 | 2019 | 3773 | 0.100 |
Why?
|
| Adiposity | 2 | 2019 | 1895 | 0.100 |
Why?
|
| Alkanes | 1 | 2011 | 39 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 2057 | 0.090 |
Why?
|
| Medicare | 8 | 2024 | 6888 | 0.090 |
Why?
|
| Brain Ischemia | 3 | 2013 | 3008 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 1399 | 0.090 |
Why?
|
| Silicones | 2 | 2022 | 228 | 0.090 |
Why?
|
| State Health Plans | 1 | 2013 | 220 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2017 | 810 | 0.090 |
Why?
|
| Macrophages, Alveolar | 2 | 2006 | 415 | 0.090 |
Why?
|
| Software | 2 | 2018 | 4480 | 0.090 |
Why?
|
| Mothers | 5 | 2018 | 2211 | 0.090 |
Why?
|
| Verbal Learning | 2 | 2023 | 465 | 0.090 |
Why?
|
| Probability | 3 | 2023 | 2483 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6242 | 0.090 |
Why?
|
| Fatigue | 1 | 2018 | 1557 | 0.090 |
Why?
|
| Stachybotrys | 1 | 2010 | 1 | 0.090 |
Why?
|
| Maximal Midexpiratory Flow Rate | 2 | 2020 | 75 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 521 | 0.090 |
Why?
|
| Wechsler Scales | 2 | 2021 | 258 | 0.090 |
Why?
|
| Congenital Abnormalities | 2 | 2014 | 703 | 0.090 |
Why?
|
| Southeastern United States | 3 | 2015 | 93 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2018 | 3591 | 0.090 |
Why?
|
| Students | 2 | 2017 | 1744 | 0.090 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 12798 | 0.090 |
Why?
|
| Single-Blind Method | 4 | 2017 | 1585 | 0.090 |
Why?
|
| Case-Control Studies | 7 | 2018 | 22294 | 0.090 |
Why?
|
| Mycotoxins | 1 | 2010 | 35 | 0.090 |
Why?
|
| Propensity Score | 2 | 2021 | 1968 | 0.090 |
Why?
|
| Lectins | 1 | 2012 | 490 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5801 | 0.080 |
Why?
|
| Methylmercury Compounds | 1 | 2011 | 103 | 0.080 |
Why?
|
| Risk Assessment | 12 | 2020 | 24330 | 0.080 |
Why?
|
| Alabama | 2 | 2024 | 112 | 0.080 |
Why?
|
| Sulfur Dioxide | 3 | 2019 | 178 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 1246 | 0.080 |
Why?
|
| Vasodilation | 1 | 2014 | 967 | 0.080 |
Why?
|
| Sulfonic Acids | 2 | 2021 | 102 | 0.080 |
Why?
|
| Exercise | 3 | 2023 | 5953 | 0.080 |
Why?
|
| Databases, Factual | 5 | 2017 | 8095 | 0.080 |
Why?
|
| Pilot Projects | 6 | 2019 | 8742 | 0.080 |
Why?
|
| Electrocardiography | 8 | 2017 | 6413 | 0.080 |
Why?
|
| Eligibility Determination | 1 | 2013 | 421 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2013 | 674 | 0.080 |
Why?
|
| Aorta | 1 | 2017 | 2046 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2026 | 0.080 |
Why?
|
| Visual Perception | 1 | 2017 | 1407 | 0.080 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 368 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2015 | 1058 | 0.080 |
Why?
|
| Uncertainty | 1 | 2014 | 769 | 0.080 |
Why?
|
| Hypotension, Orthostatic | 1 | 2012 | 258 | 0.080 |
Why?
|
| Catalase | 3 | 2016 | 215 | 0.080 |
Why?
|
| Fatty Acids | 3 | 2022 | 1812 | 0.080 |
Why?
|
| California | 2 | 2018 | 1443 | 0.080 |
Why?
|
| Cell Count | 2 | 2011 | 1833 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 474 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2015 | 1203 | 0.080 |
Why?
|
| Bronchitis | 3 | 2014 | 194 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1665 | 0.080 |
Why?
|
| Calcinosis | 1 | 2017 | 1481 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3683 | 0.080 |
Why?
|
| Ventricular Function | 1 | 2010 | 406 | 0.070 |
Why?
|
| Athletic Injuries | 1 | 2018 | 1245 | 0.070 |
Why?
|
| Oxygen | 2 | 2014 | 4273 | 0.070 |
Why?
|
| Glucose | 2 | 2017 | 4352 | 0.070 |
Why?
|
| Population Density | 2 | 2018 | 193 | 0.070 |
Why?
|
| Motor Vehicles | 1 | 2009 | 280 | 0.070 |
Why?
|
| Cadmium | 2 | 2022 | 217 | 0.070 |
Why?
|
| Microspheres | 2 | 2008 | 789 | 0.070 |
Why?
|
| Independent Living | 1 | 2012 | 584 | 0.070 |
Why?
|
| Insect Control | 1 | 2007 | 28 | 0.070 |
Why?
|
| Heart Failure | 3 | 2024 | 11879 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 494 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2012 | 4356 | 0.070 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2007 | 221 | 0.070 |
Why?
|
| Postural Balance | 1 | 2012 | 639 | 0.070 |
Why?
|
| Sex | 2 | 2017 | 53 | 0.070 |
Why?
|
| DNA Damage | 1 | 2017 | 2472 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2018 | 1436 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4879 | 0.070 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 20244 | 0.070 |
Why?
|
| Multivariate Analysis | 5 | 2019 | 12093 | 0.070 |
Why?
|
| Reaction Time | 1 | 2013 | 2102 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.070 |
Why?
|
| Overweight | 1 | 2018 | 2445 | 0.070 |
Why?
|
| Histones | 1 | 2017 | 2603 | 0.070 |
Why?
|
| Myocardium | 5 | 2011 | 4790 | 0.070 |
Why?
|
| Ectromelia | 1 | 2006 | 28 | 0.070 |
Why?
|
| Methylation | 2 | 2019 | 1078 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 1363 | 0.070 |
Why?
|
| Attention | 2 | 2015 | 2425 | 0.070 |
Why?
|
| Leptin | 1 | 2014 | 1597 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2007 | 192 | 0.070 |
Why?
|
| Weight Loss | 1 | 2018 | 2720 | 0.070 |
Why?
|
| Public Housing | 1 | 2007 | 140 | 0.060 |
Why?
|
| Patella | 3 | 2016 | 317 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1521 | 0.060 |
Why?
|
| Glutamate-Cysteine Ligase | 2 | 2016 | 23 | 0.060 |
Why?
|
| Heart Diseases | 5 | 2014 | 2819 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2011 | 21187 | 0.060 |
Why?
|
| Teratogens | 2 | 2003 | 119 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 2 | 2022 | 557 | 0.060 |
Why?
|
| Spirometry | 2 | 2022 | 929 | 0.060 |
Why?
|
| Lung Diseases | 3 | 2007 | 1943 | 0.060 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2016 | 56 | 0.060 |
Why?
|
| Vitamin D | 1 | 2019 | 3311 | 0.060 |
Why?
|
| Macrophages | 2 | 2011 | 5800 | 0.060 |
Why?
|
| Hypotension | 1 | 2011 | 888 | 0.060 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 144 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1321 | 0.060 |
Why?
|
| Memory, Short-Term | 2 | 2022 | 1010 | 0.060 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2007 | 219 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4428 | 0.060 |
Why?
|
| Poverty Areas | 1 | 2006 | 269 | 0.060 |
Why?
|
| Rain | 2 | 2003 | 60 | 0.060 |
Why?
|
| Bronchitis, Chronic | 2 | 2002 | 82 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 917 | 0.060 |
Why?
|
| Nutritional Status | 2 | 2018 | 1627 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 436 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2517 | 0.060 |
Why?
|
| Tibia | 3 | 2016 | 1076 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2017 | 6610 | 0.060 |
Why?
|
| Carbanilides | 1 | 2024 | 18 | 0.060 |
Why?
|
| Weight Gain | 1 | 2015 | 2359 | 0.060 |
Why?
|
| HIV Infections | 3 | 2020 | 17589 | 0.060 |
Why?
|
| Blood Pressure Determination | 2 | 2020 | 646 | 0.060 |
Why?
|
| Ghana | 2 | 2017 | 319 | 0.060 |
Why?
|
| Biomass | 2 | 2015 | 131 | 0.060 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2149 | 0.060 |
Why?
|
| Automobile Driving | 1 | 2009 | 442 | 0.060 |
Why?
|
| Algorithms | 5 | 2019 | 14199 | 0.060 |
Why?
|
| Quality Control | 2 | 2005 | 836 | 0.060 |
Why?
|
| Lymphocytes | 3 | 2019 | 2614 | 0.060 |
Why?
|
| Midwestern United States | 1 | 2023 | 70 | 0.060 |
Why?
|
| Mid-Atlantic Region | 2 | 2014 | 24 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2009 | 1009 | 0.060 |
Why?
|
| Face | 3 | 2005 | 1031 | 0.050 |
Why?
|
| Space-Time Clustering | 2 | 2016 | 45 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2006 | 856 | 0.050 |
Why?
|
| Age Determination by Teeth | 1 | 2003 | 11 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2011 | 840 | 0.050 |
Why?
|
| Hexachlorobenzene | 1 | 2023 | 26 | 0.050 |
Why?
|
| Bone and Bones | 2 | 2011 | 2589 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 12873 | 0.050 |
Why?
|
| Complex Mixtures | 1 | 2022 | 29 | 0.050 |
Why?
|
| Ethmoid Bone | 1 | 2003 | 35 | 0.050 |
Why?
|
| Androgens | 2 | 2022 | 1285 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2426 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2007 | 1160 | 0.050 |
Why?
|
| Tooth Abnormalities | 1 | 2003 | 56 | 0.050 |
Why?
|
| Menstruation Disturbances | 1 | 2024 | 143 | 0.050 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 273 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 2 | 2016 | 364 | 0.050 |
Why?
|
| Radiography, Panoramic | 1 | 2003 | 112 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 85 | 0.050 |
Why?
|
| Dermatoglyphics | 1 | 2002 | 21 | 0.050 |
Why?
|
| Age Determination by Skeleton | 1 | 2003 | 126 | 0.050 |
Why?
|
| Swimming | 1 | 2003 | 210 | 0.050 |
Why?
|
| Enterococcus | 1 | 2003 | 159 | 0.050 |
Why?
|
| Breath Tests | 2 | 2018 | 300 | 0.050 |
Why?
|
| Memory | 3 | 2017 | 2210 | 0.050 |
Why?
|
| Medicaid | 2 | 2013 | 2843 | 0.050 |
Why?
|
| Arteries | 1 | 2007 | 1126 | 0.050 |
Why?
|
| Sick Building Syndrome | 1 | 2021 | 17 | 0.050 |
Why?
|
| CpG Islands | 2 | 2019 | 1210 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2007 | 524 | 0.050 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 18366 | 0.050 |
Why?
|
| Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 984 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2024 | 727 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13593 | 0.050 |
Why?
|
| Baltimore | 3 | 2007 | 234 | 0.050 |
Why?
|
| Consciousness | 1 | 2007 | 602 | 0.050 |
Why?
|
| Research Design | 5 | 2024 | 6213 | 0.050 |
Why?
|
| Tanzania | 2 | 2016 | 1404 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 1737 | 0.050 |
Why?
|
| Gene Dosage | 2 | 2020 | 1222 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2017 | 2280 | 0.050 |
Why?
|
| Fertilization | 1 | 2022 | 197 | 0.050 |
Why?
|
| Cephalometry | 1 | 2003 | 380 | 0.050 |
Why?
|
| Social Environment | 2 | 2017 | 1016 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2013 | 515 | 0.050 |
Why?
|
| Antioxidants | 3 | 2020 | 1673 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11262 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2006 | 2088 | 0.040 |
Why?
|
| Michigan | 1 | 2001 | 336 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2019 | 16051 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2021 | 367 | 0.040 |
Why?
|
| Ethylene Glycol | 1 | 2000 | 31 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2018 | 7148 | 0.040 |
Why?
|
| Pliability | 1 | 2019 | 58 | 0.040 |
Why?
|
| Skull Base | 1 | 2003 | 294 | 0.040 |
Why?
|
| Ferritins | 1 | 2023 | 600 | 0.040 |
Why?
|
| Ohio | 2 | 2014 | 321 | 0.040 |
Why?
|
| Chromium | 1 | 2020 | 133 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2002 | 593 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 2149 | 0.040 |
Why?
|
| Problem Solving | 1 | 2022 | 443 | 0.040 |
Why?
|
| Maxilla | 1 | 2003 | 489 | 0.040 |
Why?
|
| Hospitals | 2 | 2024 | 3903 | 0.040 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2019 | 119 | 0.040 |
Why?
|
| Anxiety | 3 | 2023 | 4677 | 0.040 |
Why?
|
| Esters | 1 | 2020 | 212 | 0.040 |
Why?
|
| Glioma | 2 | 2012 | 3532 | 0.040 |
Why?
|
| Lagomorpha | 1 | 1999 | 7 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2015 | 6740 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 245 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
| Emergency Service, Hospital | 3 | 2014 | 7956 | 0.040 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2019 | 18 | 0.040 |
Why?
|
| Luciferases | 1 | 2021 | 713 | 0.040 |
Why?
|
| Fertility | 1 | 2024 | 770 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2020 | 615 | 0.040 |
Why?
|
| Hospitals, Community | 3 | 1986 | 365 | 0.040 |
Why?
|
| Trace Elements | 1 | 2020 | 193 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 47 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 1982 | 289 | 0.040 |
Why?
|
| Pneumonia | 2 | 2002 | 2163 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 3233 | 0.040 |
Why?
|
| Vitamins | 2 | 2023 | 1638 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 1751 | 0.040 |
Why?
|
| Canada | 2 | 2019 | 2129 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 1104 | 0.040 |
Why?
|
| Illinois | 1 | 2018 | 120 | 0.040 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2018 | 54 | 0.040 |
Why?
|
| Geographic Information Systems | 2 | 2013 | 283 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 1183 | 0.040 |
Why?
|
| Phenotype | 4 | 2019 | 16735 | 0.040 |
Why?
|
| Mandible | 1 | 2003 | 759 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2018 | 148 | 0.040 |
Why?
|
| India | 2 | 2015 | 2325 | 0.040 |
Why?
|
| Vital Statistics | 1 | 2017 | 31 | 0.040 |
Why?
|
| Air Conditioning | 1 | 2017 | 54 | 0.040 |
Why?
|
| New Hampshire | 1 | 2017 | 174 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4642 | 0.040 |
Why?
|
| Forecasting | 2 | 2019 | 2946 | 0.040 |
Why?
|
| Rest | 2 | 2018 | 951 | 0.040 |
Why?
|
| Brain | 2 | 2015 | 27476 | 0.040 |
Why?
|
| Exercise Test | 1 | 2005 | 2187 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2695 | 0.040 |
Why?
|
| Mites | 1 | 2017 | 46 | 0.040 |
Why?
|
| Eosinophils | 1 | 2022 | 953 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 1502 | 0.030 |
Why?
|
| Afghanistan | 1 | 2017 | 78 | 0.030 |
Why?
|
| Heating | 1 | 2017 | 104 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2002 | 790 | 0.030 |
Why?
|
| Rhode Island | 1 | 2017 | 352 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 2222 | 0.030 |
Why?
|
| Cyclins | 1 | 2019 | 606 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 859 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 1752 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 326 | 0.030 |
Why?
|
| Quality of Life | 3 | 2024 | 13510 | 0.030 |
Why?
|
| Netherlands | 1 | 2021 | 2277 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14751 | 0.030 |
Why?
|
| Middle East | 1 | 2017 | 233 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 160 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2019 | 373 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7885 | 0.030 |
Why?
|
| Estrogens | 1 | 2022 | 1537 | 0.030 |
Why?
|
| Dyspnea | 1 | 2024 | 1352 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2019 | 3442 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 1423 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 96 | 0.030 |
Why?
|
| Diabetes Mellitus | 3 | 2012 | 5892 | 0.030 |
Why?
|
| New Jersey | 1 | 2016 | 296 | 0.030 |
Why?
|
| Israel | 1 | 2018 | 726 | 0.030 |
Why?
|
| Sperm Count | 1 | 2016 | 229 | 0.030 |
Why?
|
| Monte Carlo Method | 2 | 2012 | 1262 | 0.030 |
Why?
|
| Cats | 1 | 2017 | 978 | 0.030 |
Why?
|
| Urbanization | 1 | 2016 | 100 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 348 | 0.030 |
Why?
|
| Wavelet Analysis | 1 | 2015 | 56 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 5520 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2012 | 9213 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 30044 | 0.030 |
Why?
|
| Ions | 1 | 2016 | 256 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 1996 | 360 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 1424 | 0.030 |
Why?
|
| Skin Tests | 1 | 2017 | 639 | 0.030 |
Why?
|
| Uric Acid | 1 | 2021 | 806 | 0.030 |
Why?
|
| Maternal Age | 1 | 2018 | 804 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 2018 | 518 | 0.030 |
Why?
|
| Veterans Health | 1 | 2016 | 216 | 0.030 |
Why?
|
| Time | 1 | 2016 | 552 | 0.030 |
Why?
|
| Oral Health | 1 | 2020 | 493 | 0.030 |
Why?
|
| Pipecolic Acids | 1 | 1995 | 77 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 771 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1982 | 1039 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2017 | 963 | 0.030 |
Why?
|
| North Carolina | 4 | 2007 | 329 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2016 | 236 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 436 | 0.030 |
Why?
|
| Sleep | 1 | 2010 | 4820 | 0.030 |
Why?
|
| Demography | 1 | 2019 | 1643 | 0.030 |
Why?
|
| Gambia | 1 | 2014 | 104 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 733 | 0.030 |
Why?
|
| Alu Elements | 1 | 2014 | 115 | 0.030 |
Why?
|
| Vitamin E | 1 | 2018 | 874 | 0.030 |
Why?
|
| Indians, North American | 1 | 2017 | 354 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 735 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 829 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1945 | 0.030 |
Why?
|
| Motor Skills | 1 | 2016 | 523 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1360 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2023 | 2421 | 0.030 |
Why?
|
| Mice | 6 | 2022 | 82074 | 0.030 |
Why?
|
| Observer Variation | 2 | 2013 | 2623 | 0.030 |
Why?
|
| Cyprus | 1 | 2013 | 96 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 508 | 0.030 |
Why?
|
| Public Health Administration | 1 | 2015 | 242 | 0.030 |
Why?
|
| China | 1 | 2019 | 2395 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2018 | 2445 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 354 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2013 | 211 | 0.030 |
Why?
|
| Parents | 2 | 2018 | 3597 | 0.030 |
Why?
|
| Registries | 2 | 2019 | 8384 | 0.030 |
Why?
|
| Intracranial Aneurysm | 1 | 1982 | 1293 | 0.030 |
Why?
|
| Life Style | 1 | 2024 | 3931 | 0.030 |
Why?
|
| Texas | 1 | 2013 | 410 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 332 | 0.020 |
Why?
|
| Carbamazepine | 2 | 2005 | 224 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2024 | 81892 | 0.020 |
Why?
|
| Base Composition | 1 | 2012 | 291 | 0.020 |
Why?
|
| Health Services | 1 | 2017 | 755 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2015 | 809 | 0.020 |
Why?
|
| Thromboplastin | 1 | 2014 | 288 | 0.020 |
Why?
|
| Comorbidity | 2 | 2017 | 10591 | 0.020 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 135 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2013 | 211 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.020 |
Why?
|
| Plethysmography, Whole Body | 1 | 2011 | 25 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 348 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 1376 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2875 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2012 | 182 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8745 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 588 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 977 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1813 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 624 | 0.020 |
Why?
|
| Species Specificity | 2 | 2010 | 2419 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.020 |
Why?
|
| New York City | 1 | 2013 | 737 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 463 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 144 | 0.020 |
Why?
|
| New York | 4 | 2004 | 884 | 0.020 |
Why?
|
| Oximetry | 1 | 2014 | 462 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2005 | 3985 | 0.020 |
Why?
|
| Genomics | 1 | 2006 | 5928 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2228 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1917 | 0.020 |
Why?
|
| Half-Life | 1 | 2011 | 651 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1757 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 939 | 0.020 |
Why?
|
| Spores, Fungal | 1 | 2010 | 90 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2012 | 611 | 0.020 |
Why?
|
| Lipids | 2 | 2016 | 3345 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3346 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1610 | 0.020 |
Why?
|
| Child Welfare | 1 | 2014 | 523 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 342 | 0.020 |
Why?
|
| Homocystine | 1 | 1989 | 21 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 905 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1389 | 0.020 |
Why?
|
| Filtration | 1 | 2010 | 228 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 706 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1966 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 799 | 0.020 |
Why?
|
| Epilepsy | 2 | 2002 | 3326 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 710 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1758 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2000 | 1541 | 0.020 |
Why?
|
| Public Health | 2 | 2015 | 2680 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
| San Francisco | 1 | 2008 | 166 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 979 | 0.020 |
Why?
|
| Insulin | 1 | 2023 | 6610 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4148 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 2014 | 492 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5505 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2014 | 1575 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2396 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2012 | 10115 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 6232 | 0.020 |
Why?
|
| Floors and Floorcoverings | 1 | 2007 | 27 | 0.020 |
Why?
|
| Weights and Measures | 1 | 2007 | 41 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 268 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3811 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 906 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 557 | 0.020 |
Why?
|
| Beds | 1 | 2007 | 48 | 0.020 |
Why?
|
| Sputum | 1 | 2010 | 517 | 0.020 |
Why?
|
| Body Weight | 1 | 2018 | 4628 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2007 | 104 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2007 | 194 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2008 | 317 | 0.020 |
Why?
|
| Telomerase | 1 | 2012 | 753 | 0.020 |
Why?
|
| Missouri | 1 | 2007 | 113 | 0.020 |
Why?
|
| Small-Area Analysis | 1 | 2006 | 51 | 0.020 |
Why?
|
| Genotype | 2 | 2013 | 13048 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2006 | 104 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2014 | 786 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3348 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 4456 | 0.020 |
Why?
|
| Deferoxamine | 1 | 2006 | 155 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 2771 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2492 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 1761 | 0.020 |
Why?
|
| Homocysteine | 1 | 1989 | 637 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 2194 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2018 | 3726 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 9081 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1796 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 722 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2007 | 308 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2006 | 2087 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2013 | 862 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 3163 | 0.020 |
Why?
|
| Transportation | 1 | 2007 | 217 | 0.020 |
Why?
|
| Ventilation | 1 | 2006 | 129 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2013 | 1783 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 2226 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1989 | 746 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 2009 | 893 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 915 | 0.020 |
Why?
|
| DNA Repair | 1 | 2014 | 2054 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 2914 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 2004 | 63 | 0.010 |
Why?
|
| Alleles | 1 | 2016 | 6901 | 0.010 |
Why?
|
| Rivers | 1 | 2004 | 65 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2016 | 4541 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1986 | 447 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 1748 | 0.010 |
Why?
|
| Chile | 1 | 2005 | 258 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4251 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5544 | 0.010 |
Why?
|
| Facies | 1 | 2005 | 224 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2014 | 2121 | 0.010 |
Why?
|
| Cytokines | 1 | 2019 | 7453 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 392 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2003 | 153 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2005 | 505 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 472 | 0.010 |
Why?
|
| Mutation | 2 | 2021 | 30266 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6085 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2003 | 486 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2593 | 0.010 |
Why?
|
| Mental Health | 1 | 2018 | 3275 | 0.010 |
Why?
|
| Polysomnography | 1 | 2010 | 1871 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 328 | 0.010 |
Why?
|
| Acute Disease | 2 | 2009 | 7245 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 742 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10778 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2013 | 2898 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 384 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4363 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3814 | 0.010 |
Why?
|
| Caseins | 1 | 2003 | 105 | 0.010 |
Why?
|
| Polyethylene | 1 | 2004 | 187 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2013 | 12469 | 0.010 |
Why?
|
| Coronary Disease | 2 | 2012 | 5919 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5323 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 413 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1724 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2010 | 2674 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2006 | 1064 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 367 | 0.010 |
Why?
|
| Food | 1 | 2007 | 768 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 1087 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2813 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 361 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12430 | 0.010 |
Why?
|
| Oregon | 3 | 1986 | 149 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 301 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 2960 | 0.010 |
Why?
|
| Epiphyses | 1 | 2002 | 191 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2003 | 272 | 0.010 |
Why?
|
| Spleen | 1 | 2007 | 2294 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2003 | 677 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 18065 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1065 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2123 | 0.010 |
Why?
|
| Health Status | 1 | 2014 | 4095 | 0.010 |
Why?
|
| Travel | 1 | 2006 | 805 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2000 | 131 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2604 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7602 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3608 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9549 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 2299 | 0.010 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1999 | 51 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 22381 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15471 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 665 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 8090 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2002 | 1169 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2003 | 708 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 1645 | 0.010 |
Why?
|
| Valproic Acid | 1 | 2001 | 444 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 1243 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1999 | 412 | 0.010 |
Why?
|
| Water | 1 | 2004 | 1421 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4941 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 5794 | 0.010 |
Why?
|
| Epitopes | 1 | 2003 | 2529 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2007 | 3124 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2402 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1560 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5864 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1999 | 1530 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 5621 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1379 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1995 | 452 | 0.010 |
Why?
|
| Coma | 2 | 1986 | 487 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15955 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7057 | 0.010 |
Why?
|
| Liver | 1 | 2007 | 7579 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19023 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 6001 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 5905 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1995 | 1345 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 4919 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 1539 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1999 | 9384 | 0.000 |
Why?
|
| Cerebral Infarction | 1 | 1986 | 975 | 0.000 |
Why?
|
| Ischemic Attack, Transient | 1 | 1986 | 877 | 0.000 |
Why?
|
| Employment | 1 | 1986 | 1114 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 20776 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1986 | 1320 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1986 | 2433 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 36861 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 2660 | 0.000 |
Why?
|